Late Market Roundup (TXN, NOK, GS, AAPY, PEP)

Shares of Texas Instruments TXN moved down after the company posted a three-fold rise in its Q2 profit, while its revenue for the same period missed Wall Street expectations, with Nokia Corp NOK reporting weaker-than-expected sales. The Philadelphia Semiconductor Index (SOX) also dipped 1.77%. Shares of Goldman Sachs Group Inc GS have narrowed their losses marginally, after moving down as much as 2.6%. The bank reported its Q2 EPS at $0.78, hurt by its settlement with the Securities and Exchange Commission (SEC) and UK payroll tax. Fees from the Goldman's financial-advisory business grew 28% y/y. Matthew Albrecht, an analyst at Standard & Poor's Equity Research, mentioned, "The surprise came mainly in the securities services division where it appears Goldman is increasing market share despite its bad publicity." Shares of AspenBio Pharma APPY plunged more than 30%, as the company reported unsatisfactory results for its AppyScore product, which is a test designed to detect acute appendicitis. The company has planned to redesign the test later this year. APPY is likely to start a pivotal clinical trial for AppyScore in 2011. Shares of PepsiCo PEP gained more than 2%, despite the company posting a 3% decline in its Q2 profit due to a downturn in North America’s food volume as well as currency fluctuations. The company has projected 11% to 13% growth in its earnings after excluding currency effects. Read more from Benzinga's Company news.